Clinical Trial Update: Efficacy and Safety of Pemafibrate for Nonalcoholic Fatty Liver Disease [Phase 2]

View source ↗

Summary

Phase 2 trial update reporting on the efficacy and safety of pemafibrate for nonalcoholic fatty liver disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonalcoholic Fatty Liver Disease

Drugs mentioned

• Pemafibrate (pemafibrate)

Snippet

Sponsor: Yokohama City University | Conditions: Non Alcoholic Fatty Liver Disease | Phase 2 | Status: ACTIVE_NOT_RECRUITING